Consistently, we found an elevation of the OCR/ECAR ratio following transfection with all siRNAs, indicating that reduced c-Myc or AURKA levels indeed shift the glycolytic to an oxidative phenotype in GBM cells. This evidence concerns the gene MYC and glioblastoma.